Lista de obras -

A common polymorphism in the annexin V Kozak sequence (-1C>T) increases translation efficiency and plasma levels of annexin V, and decreases the risk of myocardial infarction in young patients

artículo científico publicado en 2002

A pharmacogenetic effect of factor XIII valine 34 leucine polymorphism on fibrinolytic therapy for acute myocardial infarction.

artículo científico publicado en 2005

CALU A29809G polymorphism in coronary atherothrombosis: Implications for coronary calcification and prognosis.

artículo científico publicado en 2010

CALU polymorphism A29809G affects calumenin availability involving vascular calcification

artículo científico publicado en 2015

Coexistence of three genetic risk factors in a Spanish thrombophilic family: Factor V Leiden, prothrombin 20210 and a new type I antithrombin deficiency

artículo científico publicado en 2007

Comparative study of three methods to detect free plasma antiplatelet antibodies.

artículo científico publicado en 1996

Control of post-translational modifications in antithrombin during murine post-natal development by miR-200a

artículo científico publicado en 2013

Creating a genotype-based dosing algorithm for acenocoumarol steady dose.

artículo científico publicado en 2012

Detection of conformational transformation of antithrombin in blood with crossed immunoelectrophoresis: new application for a classical method

artículo científico publicado en 2003

Evaluation of leukocyte-depleted platelet concentrates obtained by in-line filtration

artículo científico publicado en 2000

Factor VII -323 decanucleotide D/I polymorphism in atrial fibrillation: implications for the prothrombotic state and stroke risk

artículo científico publicado en 2008

Factor XIII Val34Leu polymorphism modulates the prothrombotic and inflammatory state associated with atrial fibrillation.

artículo científico publicado en 2004

Factor-V (Arg506 --> Gln) mutation in ischemic cerebrovascular disease.

artículo científico publicado en 1997

Five prothrombotic polymorphisms and the prevalence of premature myocardial infarction

scientific article published on 01 March 2005

Fluctuations in coagulation activity among patients with atrial fibrillation who are stably anticoagulated.

artículo científico publicado en 2006

Genetic Polymorphisms of Platelet Adhesive Molecules: Association with Breast Cancer Risk and Clinical Presentation

artículo científico publicado en 2003

Genetic polymorphisms and atrial fibrillation: Insights into the prothrombotic state and thromboembolic risk

artículo científico publicado en 2010

Genetic polymorphisms of factor VII are not associated with arterial thrombosis

artículo científico publicado en 1998

Genotype-guided therapy improves initial acenocoumarol dosing. Results from a prospective randomised study.

artículo científico publicado en 2015

Homozygous deficiency of heparin cofactor II: relevance of P17 glutamate residue in serpins, relationship with conformational diseases, and role in thrombosis

artículo científico publicado en 2004

Implications of pharmacogenetics for oral anticoagulants metabolism.

artículo científico publicado en 2009

MiR-146a Regulates Neutrophil Extracellular Trap Formation That Predicts Adverse Cardiovascular Events in Patients With Atrial Fibrillation.

artículo científico publicado en 2018

MicroRNAs as potential regulators of platelet function and bleeding diatheses

artículo científico publicado en 2018

Pharmacogenetics in cardiovascular antithrombotic therapy

artículo científico publicado en 2005

Pharmacogenetics in cardiovascular antithrombotic therapy

artículo científico publicado en 2009

Pilot Study on the Role of Circulating miRNAs for the Improvement of the Predictive Ability of the 2MACE Score in Patients with Atrial Fibrillation

scientific article published on 12 November 2020

Plasma levels of von Willebrand factor are increased in patients with hypertrophic cardiomyopathy

scientific article published on 13 February 2010

Platelet activation and neutrophil extracellular trap (NET) formation in immune thrombocytopenia: is there an association?

scientific article published on 24 November 2019

Platelet aggregation through prothrombinase activation induced by non-aggregant doses of platelet agonists

artículo científico publicado en 2002

Polymorphisms in xenobiotic metabolizing genes (EPHX1, NQO1 and PON1) in lymphoma susceptibility: a case control study.

artículo científico publicado en 2013

Polymorphisms of platelet adhesive receptors: do they play a role in primary intracerebral hemorrhage?

artículo científico publicado en 2003

Prognostic role of MIR146A polymorphisms for cardiovascular events in atrial fibrillation.

artículo científico publicado en 2014

Role of factor XIII Val34Leu polymorphism in patients <45 years of age with acute myocardial infarction.

artículo científico publicado en 2003

Synergism between factor XII -4C>T and factor XIII Val34Leu polymorphisms in fibrinolytic therapy in acute myocardial infarction

artículo científico publicado en 2010

Synergistic association between hypercholesterolemia and the C46T factor XII polymorphism for developing premature myocardial infarction

artículo científico publicado en 2005

The pharmacogenetics of antiplatelet drugs.

artículo científico publicado en 2007

miR-146a deficiency in hematopoietic cells is not involved in the development of atherosclerosis.

artículo científico publicado en 2018

Lista de obras de

A common polymorphism in the annexin V Kozak sequence (-1C>T) increases translation efficiency and plasma levels of annexin V, and decreases the risk of myocardial infarction in young patients

A pharmacogenetic effect of factor XIII valine 34 leucine polymorphism on fibrinolytic therapy for acute myocardial infarction.

CALU A29809G polymorphism in coronary atherothrombosis: Implications for coronary calcification and prognosis.

CALU polymorphism A29809G affects calumenin availability involving vascular calcification

Coexistence of three genetic risk factors in a Spanish thrombophilic family: Factor V Leiden, prothrombin 20210 and a new type I antithrombin deficiency

Comparative study of three methods to detect free plasma antiplatelet antibodies.

Control of post-translational modifications in antithrombin during murine post-natal development by miR-200a

Creating a genotype-based dosing algorithm for acenocoumarol steady dose.

Detection of conformational transformation of antithrombin in blood with crossed immunoelectrophoresis: new application for a classical method

Evaluation of leukocyte-depleted platelet concentrates obtained by in-line filtration

Factor VII -323 decanucleotide D/I polymorphism in atrial fibrillation: implications for the prothrombotic state and stroke risk

Factor XIII Val34Leu polymorphism modulates the prothrombotic and inflammatory state associated with atrial fibrillation.

Factor-V (Arg506 --> Gln) mutation in ischemic cerebrovascular disease.

Five prothrombotic polymorphisms and the prevalence of premature myocardial infarction

Fluctuations in coagulation activity among patients with atrial fibrillation who are stably anticoagulated.

Genetic Polymorphisms of Platelet Adhesive Molecules: Association with Breast Cancer Risk and Clinical Presentation

Genetic polymorphisms and atrial fibrillation: Insights into the prothrombotic state and thromboembolic risk

Genetic polymorphisms of factor VII are not associated with arterial thrombosis

Genotype-guided therapy improves initial acenocoumarol dosing. Results from a prospective randomised study.

Homozygous deficiency of heparin cofactor II: relevance of P17 glutamate residue in serpins, relationship with conformational diseases, and role in thrombosis

Implications of pharmacogenetics for oral anticoagulants metabolism.

MiR-146a Regulates Neutrophil Extracellular Trap Formation That Predicts Adverse Cardiovascular Events in Patients With Atrial Fibrillation.

MicroRNAs as potential regulators of platelet function and bleeding diatheses

Pharmacogenetics in cardiovascular antithrombotic therapy

Pharmacogenetics in cardiovascular antithrombotic therapy

Pilot Study on the Role of Circulating miRNAs for the Improvement of the Predictive Ability of the 2MACE Score in Patients with Atrial Fibrillation

Plasma levels of von Willebrand factor are increased in patients with hypertrophic cardiomyopathy

Platelet activation and neutrophil extracellular trap (NET) formation in immune thrombocytopenia: is there an association?

Platelet aggregation through prothrombinase activation induced by non-aggregant doses of platelet agonists

Polymorphisms in xenobiotic metabolizing genes (EPHX1, NQO1 and PON1) in lymphoma susceptibility: a case control study.

Polymorphisms of platelet adhesive receptors: do they play a role in primary intracerebral hemorrhage?

Prognostic role of MIR146A polymorphisms for cardiovascular events in atrial fibrillation.

Role of factor XIII Val34Leu polymorphism in patients <45 years of age with acute myocardial infarction.

Synergism between factor XII -4C>T and factor XIII Val34Leu polymorphisms in fibrinolytic therapy in acute myocardial infarction

Synergistic association between hypercholesterolemia and the C46T factor XII polymorphism for developing premature myocardial infarction

The pharmacogenetics of antiplatelet drugs.

miR-146a deficiency in hematopoietic cells is not involved in the development of atherosclerosis.